Eli Lilly & Co. makes second major pharmaceutical deal this year by paying cancer drug specialists Loxo Oncology $8 billion.
After Samsung’s and Apple’s less than attractive financial outlooks, LG Electronics shocked investors when it hinted of about 80 percent revenue decline for its preliminary fourth-quarter...
Global debt is growing fast, and in the U.S. alone, corporate bonds has climbed 159 percent since the fourth quarter of 2017.
The world is full of possibilities, and this year could be a wild ride for the markets, but we could see significant developments in various sectors.
Big companies have set their eyes about going public this year. With analysts predicting a looming recession and the ongoing global trade tension, however, is it...
The U.S. job sector is showing signs of improvement as hundreds of thousands of jobs were created in December.
The past year had been dynamic for the currency markets. As we welcome 2019, investors might be wondering what's in store for the EURUSD market.
The market was highly volatile in 2018. Here are some predictions on how the financial market would fare this year.
With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...
The U.S. and China sat down to commence trade war talks. If both nations want to resolve the issues, then these matters must be handled first.